Center Laboratories (4123.TWO) Stock Price

Center Laboratories Price

CLOSED
30.75
​
Market closed

Revenue has compounded at 9.9% per year over the past 19 years to 1.52 B TWD. Earnings per share have grown at 28.6% per year over the last 19 years. Center Laboratories's net margin stands at 614.9%, up from 363.2% several years earlier. Center Laboratories currently offers a dividend yield of about 2.36%. The payout ratio is around 6% of earnings.

Center Laboratories stock price

Access this data via the Eulerpool API

Center Laboratories business model & stock analysis

Center Laboratories, Inc. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Taipei City, Taipei. The company went IPO on 2002-12-18. The firm's main products include dairy products and probiotic products. The firm is also involved in the manufacture, wholesale and retail of western medicines. The firm distributes its products in the domestic market and to overseas markets.

Frequently asked questions about Center Laboratories

Converted at the current exchange rate, the Center Laboratories share trades at 0.86 EUR (30.75 TWD).

The revenue cannot currently be calculated for Center Laboratories.

The profit cannot currently be calculated for Center Laboratories.

The P/E ratio cannot be calculated for Center Laboratories at the moment.

The P/S cannot be calculated for Center Laboratories currently.

The Eulerpool Quality Score for Center Laboratories is 1/10.

The ISIN of Center Laboratories is TW0004123005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Center Laboratories is 4123.TWO. The ticker symbol is used to trade Center Laboratories shares on the stock exchange.

Fair ValueTerminal
29.21 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Taiwan
Currency
TWD
Initial public offering
Dec 18, 2002
ISIN
TW0004123005
Cusip
Y1244W106
Market capitalization
22.93 B TWDLarge Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
116.84
P/B Ratio
0.87
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
32.99 %
Gross Margin
40.97 %
EBIT Margin
—
Net Margin
614.89 %
EPS (Earnings Per Share)
11.89 TWD
Net Debt / EBIT
—
Debt/Equity
0.07
Dividend
Dividend yield
2.36 %
Payout Ratio
6.09 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
21.00 %
Last updated Oct 5, 2026, 5:12 PM

Center Laboratories Peer Group

Center Laboratories Ticker

TWO · 4123.TWO

Center Laboratories FIGI

4123:TT (Taipei Stock Exchange) · BBG000NXBLG5

All fundamentals and in-depth analysis of Center Laboratories

Our stock analysis for Center Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Center Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.